Industry News
-
0311-2021
Urgent need for vaccine to prevent deadly Group B streptococcus
The global burden of Group B streptococcus is far higher than previously recognized, linked to over half a million preterm births annually, and leading to nearly 100,000 newborn deaths, at least 46,000 stillbirths, and significant long-term disability. Although the bacterium is harmless for most pregnant women who carry it, it can be extremely serious when it passes to babies during pregnancy, childbirth or in the early weeks of life. New vaccines are urgently needed to reduce deaths associated with Group B strep and protect the lives and health of infants around the world.
-
2910-2021
New ACT-Accelerator strategy calls for US$ 23.4 billion international in for COVID-19 vaccines, tests & treatmentsvestment
New ACT-Accelerator strategic plan sets out urgent actions to address crucial gaps in access to COVID-19 tests, treatments, vaccines and personal protective equipment in low- and middle-income countries, using the latest epidemiological, supply and market information.
-
2710-2021
Top economists call for radical redirection of the economy to put Health for All at the centre in the run-up to G20
The COVID-19 Pandemic has brought into focus the stark reality of the large and growing inequities across the globe in access to health care and health products: for every 100 people in high-income countries, 133 doses of COVID-19 vaccine have been administered, while in low-income countries, only 4 doses per 100 people have been administered.
-
2110-2021
WHO launches women’s health chatbot with messaging on breast cancer
WHO has launched a new interactive chatbot on women’s health. The first set of messages to be included relates to breast cancer, in time for Breast Cancer Awareness Month, observed in October every year.
-
3008-2021
https://www.who.int/news/item/27-08-2021-moving-towards-digital-documentation-of-covid-19-status
Vaccination certificates are nothing new. They are health documents that record a vaccination event - traditionally as a paper card - with key details including the date, product and batch number of the vaccine administered.
-
2008-2021
Statement by Principals of the Inter-Agency Standing Committee (IASC) on Afghanistan
The people of Afghanistan need our support now more than ever. Our organizations are committed to helping and protecting them. We will stay in Afghanistan and we will deliver.
-
1008-2021
Fraudulent “COVID-19 Compensation Lottery Prize” scam, falsely alleges association with WHO and others
The World Health Organization (WHO) has been made aware of correspondences being circulated by scammers (acting under the name of Capital Finance, Inc. London), falsely notifying recipients of such correspondences that they have been selected as a beneficiary/winner of a US$1 million lottery compensation prize payment for losses and damages suffered as a result of the COVID-19 pandemic.
-
0508-2021
Public notice and comment on new Global Validation Advisory Committee (GVAC) members
The global secretariat of the Global Validation Advisory Committee (GVAC) on the validation of elimination of mother-to-child transmission (EMTCT) of HIV, syphilis and hepatitis B virus (HBV) has considered the appointment of four new members to the committee. The new members represent the GVAC’s expanded expertise in epidemiology and response for elimination of mother-to-child transmission of HBV, in line with the incorporation of HBV for ‘triple elimination’ in the global processes and structures for EMTCT validation.
-
1507-2021
COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows
23 million children missed out on basic childhood vaccines through routine health services in 2020, the highest number since 2009 and 3.7 million more than in 2019
-
0707-2021
WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access
The World Health Organization (WHO) has updated its patient care guidelines to include interleukin-6 receptor blockers, a class of medicines that are lifesaving in patients who are severely or critically ill with COVID-19, especially when administered alongside corticosteroids.